HELP ▼ -26.5% - Helus Pharma Inc $HELP - Helus Pharma Announces Positive Topline Results from Phase 3 APPROACH Study evaluating HLP003 as Adjunctive Treatment in Major Depressive Disorder 16-NOV-2026 07:00 AM ET